Maintenance of neuronal TDP-43 expression requires axonal lysosome transport
- bioRxiv. 2025 Jun 30:2024.09.30.615241. doi: 10.1101/2024.09.30.615241.
- 1. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
- 2. Center for Alzheimer's and Related Dementias, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
- 3. Department of Chemistry, George Washington University, Washington, DC, USA.
- 4. DataTecnica, Washington, DC, USA.
- 5. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
- 6. Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, and Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.
- 7. Department of Chemistry and Biochemistry, University of Maryland, College Park, MD, USA.
TDP-43 mislocalization and pathology occurs across a range of neurodegenerative diseases, but the pathways that modulate TDP-43 in neurons are not well understood. We generated a Halo-TDP-43 knock-in iPSC line and performed a genome-wide CRISPR interference FACS-based screen to identify modifiers of TDP-43 levels in neurons. A meta-analysis of our screen and publicly available screens identified both specific hits and pathways present across multiple screens, the latter likely responsible for generic protein level maintenance. We identified BORC, a complex required for anterograde lysosome transport, as a specific modifier of TDP-43 protein, but not mRNA, levels in neurons. BORC loss led to longer half-life of TDP-43 and Other proteins, suggesting lysosome location is required for proper protein turnover. As such, lysosome location and function are crucial for maintaining TDP-43 protein levels in neurons.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: ROCKResearch Areas: Cardiovascular Disease